Medicine
Adcetris 50 mg/10.5 mL powder for injection
Adcetris 50 mg/10.5 mL powder for injection is a prescription medicine containing Brentuximab vedotin for intravenous use, marketed by Seagen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store vial refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to…
Key facts
- Active ingredient (INN)
- Brentuximab vedotin
- Brand
- Adcetris
- Strength
- 50 mg/10.5 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Seagen
- Manufacturer
- Seagen
- Origin register
- US FDA, United States
- Storage
- Store vial refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01FX05 Brentuximab vedotin
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 August 2011
- Identifiers
- RxCUI 1147323, 1147327DailyMed set ID 3904f8dd-1aef-3490-e48f-bd55f32ed67fNDC 51144-050Application BLA125388
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 box / 10.5 mL in 1 vial, single-dose | 51144-050-01 | Seagen | 25 August 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Brentuximab vedotin is a CD30-directed immunoconjugate indicated for treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vinblastine, and dacarbazine, among other approved uses. MedsAcross supplies Brentuximab vedotin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Brentuximab vedotinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ADCETRIS prescribing information (Seagen) · U.S. National Library of Medicine, DailyMed
- Adcetris: European public assessment report (EPAR) · European Medicines Agency
Need Adcetris 50 mg/10.5 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.